CUPRIC CHLORIDE IN PLASTIC CONTAINER
Details
- Status
- Prescription
- First Approved
- 1986-06-26
- Routes
- INJECTION
- Dosage Forms
- INJECTABLE
CUPRIC CHLORIDE IN PLASTIC CONTAINER Approval History
What CUPRIC CHLORIDE IN PLASTIC CONTAINER Treats
1 FDA approvalsOriginally approved for its first indication in 1986 .
- Other (1)
Other
(1 approval)- • Approved indication (Jun 1986) Priority
Active Pipeline
Ongoing clinical trials by development phase
Key Completed Trials
Completed studies with published results, ranked by significance
Trial Timeline
Full development history with FDA approval milestones
Understanding FDA Approval Types
| Count | Type | What it means |
|---|---|---|
| - | ORIG | Original approval - drug first enters market |
| - | SUPPL - Efficacy | New indication (new disease/condition approved) |
| - | SUPPL - Labeling | Label text changes (warnings, dosing updates) |
| - | SUPPL - Manufacturing | Production changes (new facility) |
| - | SUPPL - Chemistry | Formulation changes (new dosage strength) |
Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.
CUPRIC CHLORIDE IN PLASTIC CONTAINER FDA Label Details
ProIndications & Usage
FDA Label (PDF)Cupric chloride injection 0.4 mg/mL is indicated for use as a supplement to intravenous solutions given for total parenteral nutrition (TPN). Administration helps to maintain copper serum levels and to prevent depletion of endogenous stores and subsequent deficiency symptoms.
Want competitive intelligence?
See who's developing similar drugs and track their progress
Data Sources
Data sourced from official FDA and NIH databases. Click links to verify on original sources.